Research ArticleOriginal Articles
Open Access

Celecoxib as an adjuvant to chemotherapy for patients with metastatic colorectal cancer

A randomized controlled clinical study

Tarek M. Mostafa, Mohamed A. Alm El-Din and Amira R. Rashdan
Saudi Medical Journal January 2022, 43 (1) 37-44; DOI: https://doi.org/10.15537/smj.2022.43.1.20210574

Article Information

vol. 43 no. 1 37-44
DOI 
https://doi.org/10.15537/smj.2022.43.1.20210574
PubMed 
35022282
Published By 
Saudi Medical Journal
Online ISSN 
1658-3175
History 
  • Received July 15, 2021
  • Accepted November 3, 2021
  • Published online January 11, 2022.
Copyright & Usage 
Copyright: © Saudi Medical Journal This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

  1. Tarek M. Mostafa, PhD,
  2. Mohamed A. Alm El-Din, MD, PhD and
  3. Amira R. Rashdan, BSc⇑
  1. From the Department of Clinical Pharmacy (Mostafa, Rashdan), Faculty of Pharmacy; and from the Department of Clinical Oncology (Alm El-Din), Faculty of Medicine, Tanta University, Tanta, Egypt.
  1. Address correspondence and reprint request to: Dr. Amira R. Rashdan, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt. E-mail: amira.rashdan{at}pharm.tanta.edu.eg ORCID ID: https://orcid.org/0000-0003-3156-6771
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords